{"id":39475,"date":"2020-09-08T11:06:38","date_gmt":"2020-09-08T11:06:38","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=39475"},"modified":"2020-09-08T11:06:38","modified_gmt":"2020-09-08T11:06:38","slug":"treatment-ind-regulations","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/treatment-ind-regulations\/","title":{"rendered":"Treatment IND regulations"},"content":{"rendered":"<p>Food and Drug Administration (FDA) regulations promulgated in 1987, to provide a more rapid formal phannaceutical approval mechanism than the usual IND (Investigational New Drug) regulatory approval process. Its purpose is to enable drug developers to provide promising experimental drugs to patients suffering from immediately life-threatening diseases or certain serious conditions (e.g., acquired immune deficiency syndrome, or AIDS) before complete data on that drug&#8217;s efficacy or toxicity are available.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Food and Drug Administration (FDA) regulations promulgated in 1987, to provide a more rapid formal phannaceutical approval mechanism than the usual IND (Investigational New Drug) regulatory approval process. Its purpose is to enable drug developers to provide promising experimental drugs to patients suffering from immediately life-threatening diseases or certain serious conditions (e.g., acquired immune deficiency [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-39475","post","type-post","status-publish","format-standard","hentry","category-t"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Treatment IND regulations - Definition of Treatment IND regulations<\/title>\n<meta name=\"description\" content=\"Food and Drug Administration (FDA) regulations promulgated in 1987, to provide a more rapid formal phannaceutical approval mechanism than the usual IND (Investigational New Drug) regulatory approval process. Its purpose is to enable drug developers to provide promising experimental drugs to patients suffering from immediately life-threatening diseases or certain serious conditions (e.g., acquired immune deficiency syndrome, or AIDS) before complete data on that drug&#039;s efficacy or toxicity are available.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/treatment-ind-regulations\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Treatment IND regulations - Definition of Treatment IND regulations\" \/>\n<meta property=\"og:description\" content=\"Food and Drug Administration (FDA) regulations promulgated in 1987, to provide a more rapid formal phannaceutical approval mechanism than the usual IND (Investigational New Drug) regulatory approval process. Its purpose is to enable drug developers to provide promising experimental drugs to patients suffering from immediately life-threatening diseases or certain serious conditions (e.g., acquired immune deficiency syndrome, or AIDS) before complete data on that drug&#039;s efficacy or toxicity are available.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/treatment-ind-regulations\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-08T11:06:38+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/treatment-ind-regulations\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/treatment-ind-regulations\/\",\"name\":\"Treatment IND regulations - Definition of Treatment IND regulations\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-09-08T11:06:38+00:00\",\"dateModified\":\"2020-09-08T11:06:38+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Food and Drug Administration (FDA) regulations promulgated in 1987, to provide a more rapid formal phannaceutical approval mechanism than the usual IND (Investigational New Drug) regulatory approval process. Its purpose is to enable drug developers to provide promising experimental drugs to patients suffering from immediately life-threatening diseases or certain serious conditions (e.g., acquired immune deficiency syndrome, or AIDS) before complete data on that drug's efficacy or toxicity are available.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/treatment-ind-regulations\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/treatment-ind-regulations\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/treatment-ind-regulations\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Treatment IND regulations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Treatment IND regulations - Definition of Treatment IND regulations","description":"Food and Drug Administration (FDA) regulations promulgated in 1987, to provide a more rapid formal phannaceutical approval mechanism than the usual IND (Investigational New Drug) regulatory approval process. Its purpose is to enable drug developers to provide promising experimental drugs to patients suffering from immediately life-threatening diseases or certain serious conditions (e.g., acquired immune deficiency syndrome, or AIDS) before complete data on that drug's efficacy or toxicity are available.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/treatment-ind-regulations\/","og_locale":"en_US","og_type":"article","og_title":"Treatment IND regulations - Definition of Treatment IND regulations","og_description":"Food and Drug Administration (FDA) regulations promulgated in 1987, to provide a more rapid formal phannaceutical approval mechanism than the usual IND (Investigational New Drug) regulatory approval process. Its purpose is to enable drug developers to provide promising experimental drugs to patients suffering from immediately life-threatening diseases or certain serious conditions (e.g., acquired immune deficiency syndrome, or AIDS) before complete data on that drug's efficacy or toxicity are available.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/treatment-ind-regulations\/","og_site_name":"Glossary","article_published_time":"2020-09-08T11:06:38+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/treatment-ind-regulations\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/treatment-ind-regulations\/","name":"Treatment IND regulations - Definition of Treatment IND regulations","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-09-08T11:06:38+00:00","dateModified":"2020-09-08T11:06:38+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Food and Drug Administration (FDA) regulations promulgated in 1987, to provide a more rapid formal phannaceutical approval mechanism than the usual IND (Investigational New Drug) regulatory approval process. Its purpose is to enable drug developers to provide promising experimental drugs to patients suffering from immediately life-threatening diseases or certain serious conditions (e.g., acquired immune deficiency syndrome, or AIDS) before complete data on that drug's efficacy or toxicity are available.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/treatment-ind-regulations\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/treatment-ind-regulations\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/treatment-ind-regulations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Treatment IND regulations"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/39475","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=39475"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/39475\/revisions"}],"predecessor-version":[{"id":39476,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/39475\/revisions\/39476"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=39475"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=39475"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=39475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}